Abstract
Background: Body composition has emerged as an important prognostic factor in cancer patients. Sarcopenia and sarcopenic obesity (obesity with depleted muscle mass) might be predictive of morbidity and mortality in advanced breast cancer and also of toxicity to chemotherapy. We retrospectively studied patients with advanced breast cancer receiving adjuvant chemotherapy in order to determine if sarcopenia was associated with a higher incidence of toxicity and a shorter time to tumor progression.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
